Ghrelin alters postnatal endocrine secretion and behavior in mouse offspring.
Maternal bioactive substances, such as hormones and neuropeptides, are thought to be essential for fetal development. Recently, ghrelin, a gastrointestinal peptide, has been shown to pass through the rat placenta. The ghrelin receptor, growth hormone secretagogue receptor (GHS-R), has been shown to be expressed in the rat fetal central nervous system, and plasma ghrelin levels are related to birth weight in the rodent and human. In the present study, we report a role of maternal ghrelin in mouse fetal brain development. When ghrelin was administrated to pregnant mice, pups exhibited suppression of exploratory behavior in an open-field (OF) test. Control pups, however, remained for longer periods of time in the center area, correlating with exploratory behavior. Basal corticotropin-releasing hormone (CRH) plasma levels were greater in pups from ghrelin-treated dams, and did not change in response to acute restraint stress. Moreover, reduced growth hormone secretagogue receptor and neuropeptide Y mRNA expression was observed in the hypothalamus at postnatal day 3 and remained until 16 weeks of age. In addition, under physiological condition, increased maternal ghrelin plasma levels following repeated restraint stress to the dam had effect on the increase in fetal plasma acyl ghrelin levels. These results suggest that maternal ghrelin affect fetal plasma ghrelin levels and alters endocrine systems and behaviors of offspring.
Kodomari
Ikuko
I
Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashi, Kodaira, Tokyo, Japan.
Maruoka
Takashi
T
Yamauchi
Rena
R
Wada
Etsuko
E
Wada
Keiji
K
D000375:Aging / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology*; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D005106:Exploratory Behavior / Q000187:drug effects / Q000502:physiology; D005260:Female; D054439:Ghrelin / Q000097:blood* / Q000494:pharmacology; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000378:metabolism*; D008431:Maternal-Fetal Exchange / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009478:Neuropeptide Y / Q000235:genetics; D009490:Neurosecretory Systems / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D010908:Pituitary Hormones, Anterior / Q000378:metabolism*; D011247:Pregnancy; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D011986:Receptors, Somatotropin / Q000187:drug effects / Q000378:metabolism; D012149:Restraint, Physical / Q000502:physiology; D013315:Stress, Psychological / Q000378:metabolism* / Q000503:physiopathology
D054439:Ghrelin; D009478:Neuropeptide Y; D010908:Pituitary Hormones, Anterior; D012333:RNA, Messenger; D011986:Receptors, Somatotropin; D003346:Corticotropin-Releasing Hormone